An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
Top Cited Papers
Open Access
- 3 August 2015
- journal article
- review article
- Published by Wiley in Brain and Behavior
- Vol. 5 (9), e00362
- https://doi.org/10.1002/brb3.362
Abstract
Background Multiple sclerosis is an acquired demyelinating disease of the central nervous system. It is the second most common cause of disability in adults in United States after head trauma. Discussion The etiology of MS is probably multifactorial, related to genetic, environmental, and several other factors. The pathogenesis is not fully understood but is believed to involve T‐cell‐mediated inflammation directed against myelin and other related proteins with a possible role for B cells. The McDonald criteria have been proposed and revised over the years to guide the diagnosis of MS and are based on clinical presentation and magnetic resonance imaging (MRI) of the brain and spinal cord to establish dissemination in time and space. The treatment of MS includes disease modification with immunomodulator drugs and symptom management to address the specific symptoms such as fatigue, spasticity, and pain. Conclusion An update on etiology, pathogenesis, diagnosis, and immunomodulatory treatment of MS is presented.Keywords
This publication has 110 references indexed in Scilit:
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisEmergencias, 2013
- An update of teriflunomide for treatment of multiple sclerosisTherapeutics and Clinical Risk Management, 2013
- Inflammatory Cortical Demyelination in Early Multiple SclerosisThe New England Journal of Medicine, 2011
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigmAnnals of Anatomy - Anatomischer Anzeiger, 2010
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Multiple sclerosisThe Lancet, 2008
- Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosisBrain, 2008
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006